A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1997
12/30/1997	US5703063 Phosphocholine conjugated steroid and carrier or diluent; increased bioavailability
12/30/1997	US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
12/30/1997	US5703054 Oligonucleotide modulation of protein kinase C
12/30/1997	US5703051 Therapeutic uses of melanin
12/30/1997	US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface
12/30/1997	US5703048 Hepatocyte growth factor
12/30/1997	US5703047 Methods and treatments for corneal healing with growth factors
12/30/1997	US5703046 Treatment method using recombinantly produced human membrane cofactor protein (MCP)
12/30/1997	US5703045 Nervous system disorders
12/30/1997	US5703044 Plant protein
12/30/1997	US5703043 Bone morphogenetic protein-10 (BMP-10) compositions
12/30/1997	US5703040 Antimicrobial proteinaceous substances produced by staphylococcus aureus
12/30/1997	US5703039 Chimeric toxins
12/30/1997	US5703038 Emhanced biological activity
12/30/1997	US5702948 Saccular collagen and compositions and methods for making and using the same
12/30/1997	US5702946 Interleukins
12/30/1997	US5702938 Human tissue plasminogen activator
12/30/1997	US5702920 Polypeptides
12/30/1997	US5702918 HIV-2 envelope polypeptides
12/30/1997	US5702917 Polynucleotides encoding human ICAM-4
12/30/1997	US5702908 Interruption of binding of MDM2 and p53 protein and therapeutic application thereof
12/30/1997	US5702906 Preferentially binds neurotropic factor-4 but does not bind nerve growth factor, brain-derived neurotropic factor, or neuronal factor
12/30/1997	US5702903 Detecting gene that has been amplified or detecting increased expression of gene products
12/30/1997	US5702902 Using gene transcript
12/30/1997	US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents
12/30/1997	US5702717 Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
12/30/1997	US5702708 Salmonicida iron regulated protein and lipopolysaccharide vaccine
12/30/1997	US5702705 Antibody methods for the treatment of a hormone-mediated disease
12/30/1997	US5702704 Antibodies to in vivo advanced glycosylation endproducts
12/30/1997	US5702702 Anticarcinogenic agents; veterinary medicine
12/30/1997	US5702699 Process for the recovery of lipophilic proteins
12/30/1997	US5702698 Promoting production of colony stimulating factor
12/30/1997	US5702697 Free radical cell damage
12/30/1997	US5702695 Osseointegration promoting implant composition, implant assembly and method therefor
12/30/1997	CA2142707C Benzo-fused lactams promote release of growth hormone
12/30/1997	CA1339608C Reg gene and protein encoded by the gene
12/30/1997	CA1339607C Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
12/30/1997	CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known
12/29/1997	EP0814164A2 A novel cDNA of direct-acting fibrinolytic serine protease
12/29/1997	EP0814159A2 Transgenic non-human animals capable of producing heterologous antibodies
12/29/1997	EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics
12/29/1997	EP0814154A2 Recombinant alphavirus vectors
12/29/1997	EP0813877A2 Method for treating congestive heart failure
12/29/1997	EP0813876A1 Cyclosporin-containing soft capsule preparations
12/29/1997	EP0813868A2 Retroviral protease inhibitors
12/29/1997	EP0813867A2 Retroviral protease inhibitors
12/29/1997	EP0813598A1 Thrombin preparation
12/29/1997	EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
12/29/1997	EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines
12/29/1997	EP0813543A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813541A1 Process for producing a protein
12/29/1997	EP0813538A1 Compositions and methods for the treatment and diagnosis of immune disorders
12/29/1997	EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997	EP0813423A1 Composition to ameliorate osteolysis and metastasis
12/29/1997	EP0813422A1 Compositions and methods for stimulating antibody class switching
12/29/1997	EP0813421A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers
12/29/1997	EP0813420A1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent
12/29/1997	EP0813419A1 Modulators of regulatory proteins
12/29/1997	EP0813416A1 Reduction of infarct volume using citicoline
12/29/1997	EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues
12/29/1997	EP0813408A1 Growth stimulating factors
12/29/1997	EP0764026A4 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
12/29/1997	EP0731711B1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/29/1997	EP0672141A4 Methods of preparing soluble, oligomeric proteins.
12/29/1997	EP0632727B1 Conjugates formed from heat shock proteins and oligo- or polysaccharides
12/29/1997	EP0631586B1 Amino procollagen 1(i) peptides
12/29/1997	EP0552296B1 Mouse monoclonal antibodies
12/29/1997	EP0546096B1 Macrophage activating factor from vitamin d binding protein
12/27/1997	CA2209006A1 Composition for prophylaxis or treatment of cerebral infarction
12/24/1997	WO1997048983A1 SCREENING COMPOUNDS FOR THE ABILITY TO ALTER THE PRODUCTION OF AMYLOID-β PEPTIDE (x-≥41)
12/24/1997	WO1997048810A1 Method of treating lactose intolerance
12/24/1997	WO1997048809A1 LIGASE ISOLATED FROM $i(MYCOBACTERIUM AVIUM)
12/24/1997	WO1997048808A1 Bacterial production of interferon-beta using low levels of sodium and potassium ions
12/24/1997	WO1997048807A1 CHEMOKINE β-15
12/24/1997	WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF
12/24/1997	WO1997048804A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses
12/24/1997	WO1997048803A1 Human protein kinase c inhibitor homolog
12/24/1997	WO1997048802A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
12/24/1997	WO1997048801A2 Polynucleotides encoding secreted proteins
12/24/1997	WO1997048800A1 Polynucleotides encoding secreted proteins from human pbmc
12/24/1997	WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins
12/24/1997	WO1997048798A1 Polynucleotide encoding secreted protein isolated from human dendritic cells
12/24/1997	WO1997048795A2 Compositions and methods for treating specific gene expression-related diseases and disorders in humans
12/24/1997	WO1997048792A1 Transgenic non-human mammals with progressive neurologic disease
12/24/1997	WO1997048729A1 Bivalent molecules that form an activating complex with an erythropoietin receptor
12/24/1997	WO1997048728A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
12/24/1997	WO1997048727A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus
12/24/1997	WO1997048725A1 Novel peptides for prevention and treatment of infection
12/24/1997	WO1997048724A2 Human metabotropic glutamate receptor
12/24/1997	WO1997048723A2 Ptp-20, pcp-2, bdp1, clk and sirp proteins and related products
12/24/1997	WO1997048721A1 Hodgkin's disease associated molecules and uses thereof
12/24/1997	WO1997048715A1 Modulation of tetraplex formation by chemical modifications of a g4-containing oligonucleotide
12/24/1997	WO1997048688A1 Thiadiazole amide mmp inhibitors
12/24/1997	WO1997048419A1 Gene therapy for obesity
12/24/1997	WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders
12/24/1997	WO1997048415A1 Laminin-5 and the formation of basement membrane structure
12/24/1997	WO1997048414A1 INSULIN PREPARATIONS CONTAINING NaCl
12/24/1997	WO1997048413A1 Insulin preparations containing carbohydrates
12/24/1997	WO1997048412A1 Long-acting galenical formulation for grf peptides

1 ... 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2678 2679 2680 2681 ... 3163